Table 1.
Strain ID | Source | AntibioticR profile | Growth MIC (Bovine Lf) | Growth MIC (Human Lf) | Biofilm Reduction (Bovine Lf) | Biofilm Reduction (Human Lf) |
---|---|---|---|---|---|---|
4 | bronchial wash | A/SI, AK, CAX, CAZ, CFT, CP, CPE, GM, LVX, MER, PI, T/S, TEI, TIM | 62.5 μg/mL * | 62.5 μg/mL * | — | — |
5 | abdominal cavity | — | 62.5 μg/mL ** | 62.5 μg/mL**** | 41% * | 62% * |
11 | urine | A/SI, CAX, CAZ, CFT, CP, LVX, MERI, PI, T/S, TE, TIM | 250 μg/mL * | 125 μg/mL ** | — | — |
13 | blood | A/SI, AK, CAX, CAZ, CFT, CP, CPE, GM, LVX, MER, PI, T/S, TEI, TIM, TO | 125 μg/mL * | 125 μg/mL *** | 77% * | 75% * |
15 | blood | A/S, AKI, CAX, CAZ, CFT, CP, CPE, GM, LVX, MER, PI, T/S, TIM, TO | 250 μg/mL *** | 62.5 μg/mL**** | 72% * | 68% * |
16 | sputum | CAX, CAZ, CFT, CP, CPEI, GM, LVX, PI, T/S, TEI, TIMI, TOI | 250 μg/mL * | 125 μg/mL * | 32% * | — |
17 | blood | AKI, CAX, CAZ, CFT, CP, CPE, GM, LVX, MER, PI, T/S, TEI, TIM, TO | 62.5 μg/mL * | 62.5 μg/mL ** | 50% * | 70% * |
19 | wound | CAXI, CFTI | <1000 μg/mL | <1000 μg/mL | — | 41% * |
31 | sputum | A/S, AK, CAX, CAZ, CFT, CP, CPE, GM, LVX, MER, PI, T/S, TE, TIM, TO | 250 μg/mL * | 125 μg/mL ** | 53% * | — |
32 | Foley catheter | A/SI, CAX, CAZ, CFT, CP, CPE, GM, LVX, MER, PI, T/S, TEI, TIM, TO | 750 μg/mL**** | 250 μg/mL ** | — | — |
35 | sputum | — | 750 μg/mL ** | 125 μg/mL * | 67% * | 76% * |
37 | wound | A/SI, AK, CAX, CAZ, CFT, CP, CPE, GM, LVXI, MER, PI, T/S, TEI, TIM, TO | 250 μg/mL * | 750 μg/mL ** | — | 68% * |
38 | sputum | A/SI, CAX, CAZ, CFT, CP, CPE, GM, LVXI, MER, PI, T/S, TIM, TO | 750 μg/mL *** | 750 μg/mL *** | — | 34% * |
79 | sputum | — | <1000 μg/mL | <1000 μg/mL | — | 38% * |
81 | wound | — | 62.5 μg/mL ** | 125 μg/mL * | — | — |
101 | wound | — | 250 μg/mL * | 125 μg/mL * | 42% * | 70% * |
112 | sputum | A/S, CAX, CAZ, CFT, CP, CPE, GM, LVX, T/S, TE, TO | 750 μg/mL *** | 250 μg/mL **** | 56% * | 84% * |
Key terms and symbols. A. baumannii strain identification (Strain ID). Source of isolation from clinical patient (Source). Antibiotic abbreviations are as follows: Ampicillin-Sulbactam (A/S), amikacin (AK), ceftriaxone (CAX), ceftazidime (CAZ), cefotaxime (CFT), ciprofloxacin (CP), cefepime (CPE), gentamicin (GM), levofloxacin (LVX), meropenem (MER), piperacillin (PI), trimethoprim-sulfamethoxazole (T/S), tetracycline (TE), ticarcillin-K clavulanate (TIM), and tobramycin (TO). Intermediate resistance is designated with a superscript (I). Minimum inhibitory concentration (MIC) was defined as the lowest concentration at which statistically significant inhibition of growth was observed, and biofilm reduction was defined as statistically significant inhibition of bacterial biofilm, determined by one-way one-way ANOVA compared to bacterial grown in medium alone (*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). For MIC analyses, bacteria were grown in increasing concentrations of either bovine lactoferrin (Bovine Lf) or human lactoferrin (Human Lf). For biofilm assays, bacteria were grown in medium alone or medium supplemented with 125 μg/mL Bovine Lf or Human Lf and percent calculated is the mean reduction in biofilm formation compared to cultures grown in medium alone.